Showing results (121-130 of 219) with videos related to

Sort By:
Pageof 22
Blood|May 15, 2010
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemiaFarhad Ravandi, Susan O'Brien, Deborah Thomas, et al.
Leukemia Research|February 16, 2006
Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndromeKaren W L Yee, Jorge Cortes, Alessandra Ferrajoli, et al.
Leukemia & Lymphoma|May 15, 2024
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemiaJennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, et al.
Cancer|December 22, 2017
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phaseKoji Sasaki, Hagop Kantarjian, Susan O'Brien, et al.
Cancer|March 26, 2003
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemiaApostolia M Tsimberidou, Hagop M Kantarjian, Jorge Cortes, et al.
Haematologica|August 24, 2014
Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failureEmma Das-Gupta, Hildegard Greinix, Ryan Jacobs, et al.
Blood Neoplasia|January 15, 2026
Phase 1B pilot study of itacitinib with alemtuzumab in patients with T-cell prolymphocytic leukemiaTapan M Kadia, Akhil Jain, Caitlin R Rausch, et al.
American Journal of Hematology|June 14, 2013
Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemiaElias Jabbour, Koichi Takahashi, Xuemei Wang, et al.
Cancer|October 12, 2018
Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemiaRita Assi, Guillermo Garcia-Manero, Farhad Ravandi, et al.
Blood|October 16, 2004
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemiasStefan Faderl, Varsha Gandhi, Susan O'Brien, et al.
Pageof 22